Ascendis Pharma ADR (ASND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ASND | RGC | EXEL | ||
| Company | Ascendis Pharma ADR | Regencell Bioscience Holdings Ltd | Exelixis Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 214.35 | 29.51 | 45.44 | ||
| High | 217.00 | 31.42 | 45.52 | ||
| Low | 205.52 | 27.15 | 43.54 | ||
| Latest | 205.83 | 27.43 | 43.96 | ||
| Change | -9.21 | -2.63 | -1.48 | ||
| % Change | -4.28% | -8.75% | -3.26% | ||
| Volume | 693,000 | 362,100 | 2,898,700 | ||
| 20-Day Average Volume | 623,550 | 915,650 | 2,527,825 | ||
| Previous Close | 215.04 | 30.06 | 45.44 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 209.83 | 29.46 | 44.62 | ||
| 20-Day Raw Stochastic | 52.72% | 20.21% | 38.23% | ||
| 20-Day Relative Strength | 48.07 | 51.66 | 51.53 | ||
| Weighted Alpha | +51.97 | +70.87 | +17.44 | ||
| Today's Opinion | 72% Buy | 88% Buy | 88% Buy | ||
| Previous Opinion | 100% Buy | 100% Buy | 100% Buy | ||
| Last Month's Opinion | 96% Buy | 56% Buy | 48% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.40% since 01/09/26 | -40.10% since 01/09/26 | -0.18% since 01/09/26 | ||
| Low | 188.08 on 01/12/26 | 27.15 on 01/16/26 | 42.05 on 01/12/26 | ||
| High | 221.75 on 01/13/26 | 50.22 on 01/12/26 | 45.77 on 01/15/26 | ||
| 1-Month | |||||
| %Chg | -2.96% since 12/16/25 | +64.25% since 12/16/25 | +5.67% since 12/16/25 | ||
| Low | 188.08 on 01/12/26 | 16.77 on 12/17/25 | 41.56 on 12/17/25 | ||
| High | 221.75 on 01/13/26 | 69.00 on 01/08/26 | 47.24 on 12/23/25 | ||
| 3-Month | |||||
| %Chg | -0.58% since 10/16/25 | +52.81% since 10/16/25 | +12.11% since 10/16/25 | ||
| Low | 186.05 on 10/20/25 | 10.33 on 11/25/25 | 33.76 on 10/20/25 | ||
| High | 229.94 on 12/12/25 | 69.00 on 01/08/26 | 47.24 on 12/23/25 | ||
| 6-Month | |||||
| %Chg | +17.35% since 07/16/25 | +79.40% since 07/16/25 | -1.90% since 07/16/25 | ||
| Low | 160.86 on 07/29/25 | 10.33 on 11/25/25 | 33.76 on 10/20/25 | ||
| High | 229.94 on 12/12/25 | 69.00 on 01/08/26 | 47.24 on 12/23/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 12,756,726 | 13,563,834 | 11,786,204 | ||
| Shares Outstanding, K | 61,977 | 494,489 | 268,112 | ||
| Annual Sales | 393,500,000 | 0 | 2,168,700,000 | ||
| Annual Net Income | -409,120,000 | -3,580,000 | 521,270,000 | ||
| Last Quarter Sales | 249,720,000 | N/A | 597,760,000 | ||
| Last Quarter Net Income | -71,290,000 | N/A | 193,580,000 | ||
| 60-Month Beta | 0.46 | 2.03 | 0.40 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.17 on 11/12/25 | N/A | 0.78 on 11/04/25 | ||
| Latest Earnings Date | 02/11/26 | 01/30/26 | 02/10/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | 02/15/18 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 19.50 | ||